We are live on
!
Find out more
BAMCO Inc Portfolio holdings
AUM
$33.1B
1-Year Est. Return
11.16%
This Fund
S&P 500
This Quarter
Est. Return
+9.86%
1 Year Est. Return
+11.16%
3 Year Est. Return
+63.39%
5 Year Est. Return
+85.45%
10 Year Est. Return
+744.36%
AUM
$47.1B
AUM Growth
+$2.99B
(+6.8%)
Cap. Flow
+$148M
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
37.37%
Holding
438
New
41
Increased
163
Reduced
139
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$673M |
| 2 |
NVEI
Nuvei Corporation Subordinate Voting Shares
NVEI
|
+$136M |
| 3 |
TSMC
TSM
|
+$126M |
| 4 |
Boyd Gaming
BYD
|
+$89.1M |
| 5 |
JD.com
JD
|
+$86.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$224M |
| 2 |
XLRN
Acceleron Pharma
XLRN
|
+$223M |
| 3 |
Zillow
ZG
|
+$217M |
| 4 |
Zillow
Z
|
+$186M |
| 5 |
Meta Platforms (Facebook)
META
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 29.82% |
| 2 | Technology | 21.39% |
| 3 | Financials | 15.2% |
| 4 | Healthcare | 13.61% |
| 5 | Real Estate | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLK
326
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $3.83M | 0.01% |
210,445
-30,426
| -13% | -$750K |
|
|
TSIBU
327
DELISTED
Tishman Speyer Innovation Corp. II Unit
TSIBU
| $3.76M | 0.01% |
381,620
-106,235
| -22% | -$1.06M |
|
328
Ventas
VTR
$47.5B
| $3.71M | 0.01% |
72,624
-5,564
| -7% | -$291K |
|
329
Crown Castle
CCI
$34.6B
| $3.6M | 0.01% |
17,260
+5,200
| +43% | +$960K |
|
|
ENV
330
DELISTED
ENVESTNET, INC.
ENV
| $3.52M | 0.01% |
44,412
| – | – |
|
331
Establishment Labs
ESTA
$2.71B
| $3.4M | 0.01% |
50,252
+14,100
| +39% | +$985K |
|
332
Pebblebrook Hotel Trust
PEB
$2.18B
| $3.27M | 0.01% |
146,190
-42,900
| -23% | -$967K |
|
333
Host Hotels & Resorts
HST
$17.5B
| $3.13M | 0.01% |
179,943
-80,992
| -31% | -$1.37M |
|
334
Archer Aviation Redeemable Warrants
ACHR.WS
$15M
| $3.02M | 0.01% |
+500,000
| New | +$641K |
|
|
NXRT
335
NexPoint Residential Trust
NXRT
$689M
| $2.93M | 0.01% |
+34,937
| New | +$2.58M |
|
|
LHCG
336
DELISTED
LHC Group LLC
LHCG
| $2.88M | 0.01% |
+21,000
| New | +$2.87M |
|
337
Certara
CERT
$1.26B
| $2.84M | 0.01% |
100,000
+51,107
| +105% | +$1.72M |
|
|
KW
338
DELISTED
Kennedy-Wilson Holdings
KW
| $2.8M | 0.01% |
117,388
+19,200
| +20% | +$437K |
|
339
Ascendis Pharma A/S
ASND
$16.5B
| $2.76M | 0.01% |
+20,500
| New | +$3.05M |
|
340
Fastenal
FAST
$54.8B
| $2.74M | 0.01% |
85,620
| – | – |
|
341
CME Group
CME
$95.4B
| $2.64M | 0.01% |
11,547
+4,473
| +63% | +$984K |
|
|
NIU
342
Niu Technologies
NIU
$200M
| $2.6M | 0.01% |
+161,592
| New | +$3.56M |
|
343
Tenet Healthcare
THC
$22.2B
| $2.57M | 0.01% |
+31,500
| New | +$2.3M |
|
344
Insulet
PODD
$11.8B
| $2.45M | 0.01% |
9,215
-4,500
| -33% | -$1.31M |
|
345
Park Hotels & Resorts
PK
$3.08B
| $2.39M | 0.01% |
126,467
-97,765
| -44% | -$1.84M |
|
346
Danaher
DHR
$138B
| $2.36M | 0.01% |
8,080
+1,512
| +23% | +$416K |
|
347
HDFC Bank
HDB
$123B
| $2.23M | ﹤0.01% |
+68,638
| New | +$2.4M |
|
348
Cytokinetics
CYTK
$10.6B
| $2.19M | ﹤0.01% |
+48,000
| New | +$1.85M |
|
|
ACC
349
DELISTED
American Campus Communities, Inc.
ACC
| $1.87M | ﹤0.01% |
+32,649
| New | +$1.74M |
|
350
Novanta
NOVT
$4.91B
| $1.84M | ﹤0.01% |
10,431
| – | – |
|
Similar funds
PPF
GAM
BAMCO Inc's Q4 2021 Portfolio in Review
As of Q4 2021, BAMCO Inc held 438 positions worth $47.1B, up 6.8% from $44.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
BAMCO Inc's Q4 2021 filing shows 41 new, 163 increased, 139 reduced and 34 closed positions. Its largest new stake was Rivian: 5,839,998 shares worth $590M. The largest sale was Tesla, an estimated $224M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 30% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- BAMCO Inc's largest Q4 2021 buy was Rivian: 5,839,998 shares worth $590M.
- BAMCO Inc added most to TSMC in Q4 2021, an estimated $126M increase.
- BAMCO Inc's biggest Q4 2021 reduction was Tesla, cutting an estimated $224M.
- BAMCO Inc fully exited Acceleron Pharma in Q4 2021, selling an estimated $223M.
- BAMCO Inc's ten largest holdings make up 37% of its $47.1B portfolio in Q4 2021.
- BAMCO Inc opened 41 new positions and closed 34 in Q4 2021.
- BAMCO Inc's portfolio value rose 6.8% quarter-over-quarter to $47.1B.
Based on BAMCO Inc's 13F filing for Q4 2021, filed 14 Feb 2022.